>> not so much, but the hhs, perrigo does not expect the fda to approve its inhaler this year, expects letter indicating they are not going to approve the application. as a result of that, they don't expect to get the pro-air generic product approved in the 40 quarter of 2018 and say, therefore, they no longer expect to achieve the about 9 cent per share benefit included in the 2018 adjusted and reported eps guidance range perrigo down 10% teva makes a competing product, and they are not seeing this competition this year according to perrigo back to you. >> thought it would be up more, but still a fractional gain, meg, thank you >>> time for a news update with sue. sue? >> heldly, kelly, hello, everyone senator rand paul speaking out about the cia nomination of fellow kentucky gina haspel who has been criticized because of her torture after 9/11 he said because of that, he is holding out support. >> we put the japanese in camp, these were dark periods in our history. we need to look to the brighter side of who we are as americans, who we are as people that does not include torture, so